Efficacy and safety of Alemtuzumab in treatment-naive patients with relapsing-remitting multiple sclerosis: Four-year follow-up of the Care-MS I study.
Montalban X, Inshasi JS, Coles AJ, Hartung HP, Havrdova E, Selmaj K, Margolin DH, Palmer J, Oyuela P
Mult Scler Relat Disord. 2014 Nov; 3(6):761-2. Epub 2014 Nov 21. PMID: 25891612.Abstract